[{"id":"a001c277-e1dc-477d-a96a-6adcd3903edc","acronym":"STEM","url":"https://clinicaltrials.gov/study/NCT00725374","created_at":"2021-01-18T02:43:51.282Z","updated_at":"2025-02-25T12:35:03.990Z","phase":"Phase 3","brief_title":"A Study to Investigate the Effects of Tibolone (Livial®) on Breast Tissue in Postmenopausal Women With Breast Cancer (Study 32971)(P06469)","source_id_and_acronym":"NCT00725374 - STEM","lead_sponsor":"Organon and Co","biomarkers":" ER","pipe":" | ","alterations":" ER positive","tags":["ER"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ER positive"],"overall_status":"Completed","enrollment":" Enrollment 102","initiation":"Initiation: 12/15/2002","start_date":" 12/15/2002","primary_txt":" Primary completion: 04/15/2005","primary_completion_date":" 04/15/2005","study_txt":" Completion: 04/15/2005","study_completion_date":" 04/15/2005","last_update_posted":"2024-08-15"},{"id":"4ebdb797-1f50-4cdd-a231-449213daaf19","acronym":"","url":"https://clinicaltrials.gov/study/NCT03941730","created_at":"2021-01-18T19:24:43.568Z","updated_at":"2024-07-02T16:34:59.610Z","phase":"Phase 2","brief_title":"Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer","source_id_and_acronym":"NCT03941730","lead_sponsor":"Mayo Clinic","biomarkers":" HER-2 • PD-L1 • PGR","pipe":" | ","alterations":" HER-2 negative","tags":["HER-2 • PD-L1 • PGR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 negative"],"overall_status":"Enrolling by invitation","enrollment":" Enrollment 38","initiation":"Initiation: 08/28/2019","start_date":" 08/28/2019","primary_txt":" Primary completion: 07/31/2026","primary_completion_date":" 07/31/2026","study_txt":" Completion: 07/31/2026","study_completion_date":" 07/31/2026","last_update_posted":"2024-06-03"},{"id":"5a4c99c4-88bf-4540-b466-6889c483ee21","acronym":"ESTHER","url":"https://clinicaltrials.gov/study/NCT05716516","created_at":"2023-02-08T18:00:21.333Z","updated_at":"2024-07-02T16:35:29.139Z","phase":"Phase 2","brief_title":"STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER)","source_id_and_acronym":"NCT05716516 - ESTHER","lead_sponsor":"Dartmouth-Hitchcock Medical Center","biomarkers":" ER","pipe":" | ","alterations":" ESR1 mutation","tags":["ER"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ESR1 mutation"],"overall_status":"Recruiting","enrollment":" Enrollment 36","initiation":"Initiation: 05/04/2023","start_date":" 05/04/2023","primary_txt":" Primary completion: 05/01/2026","primary_completion_date":" 05/01/2026","study_txt":" Completion: 05/01/2027","study_completion_date":" 05/01/2027","last_update_posted":"2023-11-15"},{"id":"aceff7a2-5092-43b8-8aad-dcf758269bb9","acronym":"","url":"https://clinicaltrials.gov/study/NCT00005847","created_at":"2021-01-17T23:51:33.434Z","updated_at":"2024-07-02T16:35:45.079Z","phase":"Phase 2","brief_title":"Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy","source_id_and_acronym":"NCT00005847","lead_sponsor":"Eastern Cooperative Oncology Group","biomarkers":" BCL2","pipe":"","alterations":" ","tags":["BCL2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e paclitaxel • vinorelbine tartrate • mitoxantrone • Emcyt (estramustine)"],"overall_status":"Completed","enrollment":"","initiation":"Initiation: 04/05/2001","start_date":" 04/05/2001","primary_txt":" Primary completion: 07/01/2004","primary_completion_date":" 07/01/2004","study_txt":"","study_completion_date":"","last_update_posted":"2023-06-22"},{"id":"74a0906c-414c-4702-90e8-85ad4e10b8c7","acronym":"","url":"https://clinicaltrials.gov/study/NCT04177693","created_at":"2022-04-25T15:53:49.431Z","updated_at":"2024-07-02T16:35:46.457Z","phase":"Phase 1","brief_title":"Pharmacokinetics and Hepatic Safety of EGCG","source_id_and_acronym":"NCT04177693","lead_sponsor":"Yale University","biomarkers":" MTHFR","pipe":" | ","alterations":" MTHFR C677T","tags":["MTHFR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MTHFR C677T"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e letrozole"],"overall_status":"Completed","enrollment":" Enrollment 39","initiation":"Initiation: 11/24/2020","start_date":" 11/24/2020","primary_txt":" Primary completion: 01/31/2022","primary_completion_date":" 01/31/2022","study_txt":" Completion: 01/31/2022","study_completion_date":" 01/31/2022","last_update_posted":"2023-06-05"},{"id":"6d778386-93bc-43df-aca0-788f12fcfb93","acronym":"PROMISE","url":"https://clinicaltrials.gov/study/NCT02694809","created_at":"2021-01-18T13:09:19.110Z","updated_at":"2024-07-02T16:35:56.250Z","phase":"Phase 2","brief_title":"The PROMISE Study: Duavee in Women With DCIS","source_id_and_acronym":"NCT02694809 - PROMISE","lead_sponsor":"Northwestern University","biomarkers":" HER-2 • PGR • CD36 • PTGS2","pipe":" | ","alterations":" HER-2 expression • PGR expression","tags":["HER-2 • PGR • CD36 • PTGS2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 expression • PGR expression"],"overall_status":"Recruiting","enrollment":" Enrollment 160","initiation":"Initiation: 01/01/2017","start_date":" 01/01/2017","primary_txt":" Primary completion: 08/01/2023","primary_completion_date":" 08/01/2023","study_txt":" Completion: 07/01/2024","study_completion_date":" 07/01/2024","last_update_posted":"2023-02-07"},{"id":"da69c7e7-102d-4aab-a50a-a190ae070b70","acronym":"","url":"https://clinicaltrials.gov/study/NCT01923298","created_at":"2021-01-18T08:40:55.972Z","updated_at":"2024-07-02T16:36:17.279Z","phase":"Phase 2","brief_title":"Estradiol Levels in Patients Treated With Estring","source_id_and_acronym":"NCT01923298","lead_sponsor":"University of Arizona","biomarkers":" ER","pipe":" | ","alterations":" ER positive","tags":["ER"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ER positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Estring (estradiol)"],"overall_status":"Completed","enrollment":" Enrollment 14","initiation":"Initiation: 08/09/2013","start_date":" 08/09/2013","primary_txt":" Primary completion: 06/30/2018","primary_completion_date":" 06/30/2018","study_txt":" Completion: 04/24/2019","study_completion_date":" 04/24/2019","last_update_posted":"2022-02-10"},{"id":"71bc2a0d-5c54-4fba-a0e8-7b6c12ec8266","acronym":"","url":"https://clinicaltrials.gov/study/NCT02718144","created_at":"2021-01-18T13:17:46.362Z","updated_at":"2024-07-02T16:36:28.879Z","phase":"Phase 1/2","brief_title":"Assessment of Safety and Efficacy of Estetrol in Postmenopausal Women With Advanced Estrogen Receptor Positive (ER+) Breast Cancer","source_id_and_acronym":"NCT02718144","lead_sponsor":"Pantarhei Oncology B.V.","biomarkers":" HER-2 • ER","pipe":" | ","alterations":" ER positive • HER-2 negative • ER positive + HER-2 negative","tags":["HER-2 • ER"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ER positive • HER-2 negative • ER positive + HER-2 negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Donesta (estetrol)"],"overall_status":"Completed","enrollment":" Enrollment 12","initiation":"Initiation: 06/01/2017","start_date":" 06/01/2017","primary_txt":" Primary completion: 12/31/2019","primary_completion_date":" 12/31/2019","study_txt":" Completion: 12/31/2019","study_completion_date":" 12/31/2019","last_update_posted":"2021-06-18"},{"id":"06f21240-c20d-439e-8665-60546964dae6","acronym":"","url":"https://clinicaltrials.gov/study/NCT02866955","created_at":"2021-01-18T14:04:25.677Z","updated_at":"2024-07-02T16:36:49.051Z","phase":"Phase 2","brief_title":"Evaluation of the Efficacy of Estramustine in Patient With Breast Cancer Progression After Treatment With Aromatase Inhibitor.","source_id_and_acronym":"NCT02866955","lead_sponsor":"Institut de Cancérologie de Lorraine","biomarkers":" HER-2","pipe":"","alterations":" ","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e tamoxifen • Emcyt (estramustine)"],"overall_status":"Completed","enrollment":" Enrollment 100","initiation":"Initiation: 06/15/2011","start_date":" 06/15/2011","primary_txt":" Primary completion: 08/08/2014","primary_completion_date":" 08/08/2014","study_txt":" Completion: 08/28/2015","study_completion_date":" 08/28/2015","last_update_posted":"2020-03-09"},{"id":"9bd1cd0e-4140-4e80-964d-a3d5cacd1551","acronym":"","url":"https://clinicaltrials.gov/study/NCT02853071","created_at":"2021-01-18T14:00:11.399Z","updated_at":"2024-07-02T16:36:53.520Z","phase":"Phase 2","brief_title":"Efficacy and Safety of Estracyt® in Metastatic Breast Cancer","source_id_and_acronym":"NCT02853071","lead_sponsor":"Centre Hospitalier Universitaire de Besancon","biomarkers":" HER-2","pipe":"","alterations":" ","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Emcyt (estramustine)"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 01/01/2017","start_date":" 01/01/2017","primary_txt":" Primary completion: 01/01/2020","primary_completion_date":" 01/01/2020","study_txt":" Completion: 01/01/2020","study_completion_date":" 01/01/2020","last_update_posted":"2019-11-18"},{"id":"ff0dc726-b22c-4eec-95db-9406c65225ad","acronym":"","url":"https://clinicaltrials.gov/study/NCT00038246","created_at":"2021-01-18T00:02:12.994Z","updated_at":"2025-02-25T14:22:50.034Z","phase":"Phase 1/2","brief_title":"Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinoma","source_id_and_acronym":"NCT00038246","lead_sponsor":"M.D. Anderson Cancer Center","biomarkers":" EGFR","pipe":"","alterations":" ","tags":["EGFR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e paclitaxel • thalidomide • Emcyt (estramustine)"],"overall_status":"Completed","enrollment":" Enrollment 40","initiation":"Initiation: 10/01/2000","start_date":" 10/01/2000","primary_txt":" Primary completion: 02/01/2004","primary_completion_date":" 02/01/2004","study_txt":" Completion: 12/01/2004","study_completion_date":" 12/01/2004","last_update_posted":"2018-10-31"}]